Abstract:BACKGROUND AND AIMS: Syndromic biliary atresia is a cholangiopathy characterized by fibro-obliterative changes in the extrahepatic bile duct (EHBD) and congenital malformations including laterality defects. The aetiology remains elusive and faithful animal models are lacking. Genetic syndromes provide important clues for underlying pathogenic mechanisms of disease. We investigated the role of the gene Pkd1l1 in syndromic biliary atresia pathophysiology.METHODS: Constitutive and conditional Pkd1l1 knockout mice were generated to explore genetic pathology as a cause of syndromic biliary atresia. We assessed for congenital malformations, EHBD and liver pathology, EHBD gene expression, and biliary epithelial cell turnover. Biliary drainage was functionally assessed with cholangiography. Histology and serum chemistries were assessed after 3,5-diethoxycarbony l-1,4-dihydrocollidine (DDC) diet treatment and inhibition of the ciliary signalling effector GLI1.RESULTS: Pkd1l1-deficient mice exhibited congenital anomalies including malrotation and heterotaxy. Pkd1l1-deficient EHBD were hypertrophic and fibrotic. Pkd1l1-deficient EHBD were patent, but displayed delayed biliary drainage. Pkd1l1-deficient livers exhibited ductular reaction and periportal fibrosis. After DDC treatment, Pkd1l1-deficient mice exhibited EHBD obstruction and advanced liver fibrosis. Pkd1l1-deficient mice had increased expression of fibrosis and extracellular matrix remodeling genes (Tgfα, Cdkn1a, Hb-egf, Fgfr3, Pdgfc, Mmp12, and Mmp15) and decreased expression of genes mediating ciliary signalling (Gli1, Gli2, Ptch1, and Ptch2). Primary cilia were reduced on biliary epithelial cells and altered expression of ciliogenesis genes occurred in Pkd1l1-deficient mice. Small molecule inhibition of the ciliary signalling effector GLI1 with Gant61 recapitulated Pkd1l1-deficiency.CONCLUSIONS: Pkd1l1 loss causes both laterality defects and fibro-proliferative EHBD transformation through disrupted ciliary signalling, phenocopying syndromic biliary atresia. Pkd1l1-deficient mice function as an authentic genetic model to study biliary atresia pathogenesis.IMPACT AND IMPLICATIONS: The syndromic form of biliary atresia is characterized by fibro-obliteration of extrahepatic bile ducts and is often accompanied by laterality defects. The aetiology is unknown, but Pkd1l1 was identified as a potential genetic candidate for syndromic biliary atresia. We found that loss of the ciliary gene Pkd1l1 contributes to hepatobiliary pathology in biliary atresia, exhibited by bile duct hypertrophy, reduced biliary drainage, and liver fibrosis in Pkd1l1-deficient mice. Pkd1l1-deficient mice serve as a genetic model of biliary atresia and reveals ciliopathy as an aetiology of biliary atresia. This model will help scientists uncover new therapeutic approaches for patients with biliary atresia and validate screening for PKD1L1 variants by paediatric hepatologists for diagnostic evaluation.

Pkd1l1-deficiency drives biliary atresia through ciliary dysfunction in biliary epithelial cells

Liver-restricted deletion of the biliary atresia candidate gene Pkd1l1 causes bile duct dysmorphogenesis and ciliopathy

Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease

PKD1L1 Is Involved in Congenital Chylothorax

Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling

Congenital biliary atresia is correlated with disrupted cell junctions and polarity caused by Cdc42 insufficiency in the liver

Biallelic Loss-of-function ZFYVE19 Mutations Are Associated with Congenital Hepatic Fibrosis, Sclerosing Cholangiopathy and High-Ggt Cholestasis

Ldl Receptor-Related Protein 6 Modulates Ret Proto-Oncogene Signaling in Renal Development and Cystic Dysplasia

Heterozygous calcyclin-binding protein/Siah1-interacting protein (CACYBP/SIP) gene pathogenic variant linked to a dominant family with paucity of interlobular bile duct

Conditional Mutation of Pkd2 Causes Cystogenesis and Upregulates Beta-Catenin.

Crosstalk of LKB1‐regulated and PTEN‐regulated Signals in Liver Morphogenesis and Tumor Development in Mice

Genetics and mechanisms of hepatic cystogenesis

Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease

Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA/S1PR2/ZBP1/p-MLKL axis

Notch‐Hes1 signaling activation in Caroli disease and polycystic liver disease

Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.

Isolated polycystic liver disease genes define effectors of polycystin-1 function

Defects of renal tubular homeostasis and cystogenesis in the Pkhd1 knockout

Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1-/- mouse model of congenital hepatic fibrosis

Cyclin-Dependent Kinase 1 Activity is a Driver of Cyst Growth in Polycystic Kidney Disease.

Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model